AdvanCell Unveils Innovative Phase 2 Design for ADVC001 in Metastatic Prostate Cancer Why are new treatment options for metastatic prostate cancer crucial? AdvanCell, a clinical-stage radiopharmaceutical company, is addressing this…
DECA Dental Group Adopts Pearl’s AI to Improve Clinical Outcomes and Patient Engagement In the rapidly evolving landscape of dental technology, the integration of artificial intelligence (AI) is becoming a…
Vir Biotechnology Seeks to Raise $200 Million in Public Offering In the competitive landscape of biopharmaceutical innovation, where securing capital is crucial for advancing groundbreaking treatments, Vir Biotechnology, Inc. stands…
Epredia and Mindpeak Announce Distribution Agreement for AI-Based Image Recognition Software As cancer cases rise and diagnostic processes become more complex, pathology laboratories face increasing pressure to speed up processes…
Preclinical Study Shows Targeted Degradation of MYC and KRAS Using Bionic Biologics Platform Why have traditional cancer treatments struggled to target the most aggressive forms of the disease? Grove Biopharma,…
Verdiva Bio Advances Obesity Therapy with Once-Weekly Oral GLP-1 Peptide Analog Is the pharmaceutical industry on the brink of a breakthrough in obesity treatment? Verdiva Bio Limited a clinical-stage biopharmaceutical company focused…
GEDC Deploys VideaAI Across 210 Practices in Just Two Weeks Is the dental industry ready for a major AI-driven transformation? VideaHealth, the leading dental AI platform, is making waves with its…
SolasCure Ltd Demonstrates Superior Wound Healing with Aurase Wound Gel Why are chronic wounds a persistent challenge for healthcare systems, and how can new treatments make a difference? SolasCure Ltd, a biotechnology…
Positive Opinion Paves Way for Phase III Trial of Acetylleucine in Rare Neurological Conditions Why are rare neurological disorders often overlooked in drug development? IntraBio Inc., an Austin, Texas-based global biopharmaceutical…
Biotech Firm to Present at Psychedelic Therapeutics Conference in New Orleans Why are current treatments for neurodegenerative diseases often limited to symptom management? Five Discovery, a biotechnology company, is addressing…
Expanding Access to Personalized Radiation Therapy for Prostate Cancer Patients Why do more than 20% of prostate cancer patients experience persistent urinary side effects after radiation therapy? MiraDx, a molecular diagnostics…
Biotech Leader OmniAb, Inc. to Showcase Cutting-Edge Antibody Discovery Technology In the rapidly evolving landscape of biotechnology, where innovation and precision are paramount, OmniAb, Inc. stands out as a leader…